UBS cpnfirms its Buy recommendation on the stock, with a target price of E110, representing upside potential of 19% ahead of the announcement of Q2 2024 results.

"Sanofi will publish its second-quarter results on Thursday July 25", says the analyst firm.

The 2024 forecast of no sales leverage has been reiterated, but in the longer term, sales growth of 5.8% should translate into EPS growth of 9.4% over the long term, so the share remains attractive', it judges.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.